1. Review article › Research › Peer-reviewed
2. Published

   New WHO Violence Prevention Information System, an interactive knowledge platform of scientific findings on violence

   Burrows, S., Butchart, A., Butler, N., Quigg, Z., Bellis, M. A. & Mikton, C., Apr 2018, In: Injury Prevention. 24, 2, p. 155-156

   Research output: Contribution to journal › Review article › peer-review

3. Published

   Optimal provision of needle and syringe programmes for injecting drug users: A systematic review

   Jones, L., Pickering, L., Sumnall, H., McVeigh, J. & Bellis, M. A., Sept 2010, In: The International Journal of Drug Policy. 21, 5, p. 335-42 8 p.

   Research output: Contribution to journal › Review article › peer-review

4. Published

   Reducing harm in drinking environments: a systematic review of effective approaches

   Jones, L., Hughes, K., Atkinson, A. M. & Bellis, M. A., Mar 2011, In: Health and Place. 17, 2, p. 508-18 11 p.

   Research output: Contribution to journal › Review article › peer-review

5. Published

   The involvement of drugs and alcohol in drug-facilitated sexual assault: a systematic review of the evidence

   Beynon, C. M., McVeigh, C., McVeigh, J., Leavey, C. & Bellis, M. A., Jul 2008, In: Trauma, violence & abuse. 9, 3, p. 178-88 11 p.

   Research output: Contribution to journal › Review article › peer-review

6. Web publication/site › Research
7. Published

   Improving Outcomes for People with Sarcoma - Analysis of Potential Economic Impact.

   Linck, P. G., Linck, P., Hughes, D. A. & Edwards, R. T., 22 Mar 2006

   Research output: Non-textual form › Web publication/site

8. Published

   Improving Outcomes in Children and Young People with Cancer: Analysis of the Potential Economic Impact of the Guidance.

   Linck, P. G., Linck, P., Tunnage, B., Hughes, D. A. & Edwards, R. T., 24 Aug 2005

   Research output: Non-textual form › Web publication/site

9. Published

   Investigating factors influencing user choices to visit either general practitioners or community pharmacists in the management of minor ailments – piloting a discrete choice experiment

   Hughes, D., Hughes, D. A., Myles, S., Longo, M. & Lisles, C., 1 Mar 2008

   Research output: Non-textual form › Web publication/site

10. Working paper › Research
11. Published

    Measuring Later Life Social Exclusion in Understanding Society

    MacLeod, C., Ross, A., Windle, G., Netuveli, G. & Sacker, A., 27 Jun 2016, The International Centre for Lifecourse Studies in Society and Health (ICLS): University College London, p. 1-14, 14 p.

    Research output: Working paper

12. Other report › Research › Peer-reviewed
13. Published

    A systematic review of cancer waiting time audits

    Lewis, R., Collins, R., Flynn, A., Dean, M. E., Myers, L., Wilson, P. & Eastwood, A., 2005, Centre for Reviews and Dissemination (CRD) University of York. 127 p.

    Research output: Book/Report › Other report › peer-review

14. Published

    Ffynonellau gwydnwch a’u cysylltiadau lliniarol gyda’r niwed sy’n cael ei achosi gan brofiadau niweidiol yn ystod plentyndod: Adroddiad 1: Salwch meddwl

    Hughes, K., Ford, K., Davies, A., Homolova, L. & Bellis, M., 18 Jan 2018, Public Health Wales NHS Trust. 60 p.

    Research output: Book/Report › Other report › peer-review

15. Published

    Sources of resilience and their moderating relationships with harms from adverse childhood experiences. Report 1: Mental illness

    Hughes, K., Ford, K., Davies, A., Homolova, L. & Bellis, M., 18 Jan 2018, Public Health Wales NHS Trust. 60 p.

    Research output: Book/Report › Other report › peer-review

16. Published

    The service of alcohol to drunks: Measuring and supporting compliance with the law in Manchester City Centre’s nightlife

    Ford, K., Quigg, Z., Butler, N. & Hughes, K., 2016, Public Health Institute, Liverpool John Moores University.

    Research output: Book/Report › Other report › peer-review

17. Other report › Research › Not peer-reviewed
18. Published

    Stay Well in Wales: the public’s views on public health. Findings from the nationally representative household survey

    Sharp, C., Hughes, K. & Bellis, M., 3 Nov 2017, Public Health Wales .

    Research output: Book/Report › Other report

19. Published

    The evaluation of the National Exercise Referral Scheme in Wales

    Murphy, S. M., Raisanen, L., Moore, G., Edwards, R., Linck, P., Hounsome, N., Williams, N., Din, N. & Moore, L., 2010, Welsh Government. (Social research; no. Number: 07/2010)

    Research output: Book/Report › Other report

20. Commissioned report › Research › Peer-reviewed
21. Published

    Byw yn dda yn hirach: Y ddadl economaidd dros fuddsoddi yn iechyd a llesiant pobl hŷn yng Nghymru

    Edwards, R., Spencer, L., Bryning, L. & Anthony, B., 30 Jul 2018, 68 p.

    Research output: Book/Report › Commissioned report › peer-review

22. Published

    Living Well for Longer: Economic argument investing in the health and wellbeing of older people in Wales

    Edwards, R., Spencer, L., Bryning, L. & Anthony, B., 30 Jul 2018, 68 p.

    Research output: Book/Report › Commissioned report › peer-review

23. Published

    Lles mewn gwaith: Y dadleuon economaidd dros fuddsoddi mewn iechyd a lles y gweithlu yng Nghymru

    Edwards, R. T., Spencer, L., Anthony, B. & Bryning, L., 17 Oct 2019, Bangor : Bangor University. 64 p.

    Research output: Book/Report › Commissioned report › peer-review

24. Published

    Transforming Young Lives across Wales: The Economic Argument for Investing in Early Years

    Edwards, R., Bryning, L. & Lloyd Williams, H., 13 Oct 2016, Prifysgol Bangor University. 110 p.

    Research output: Book/Report › Commissioned report › peer-review

25. Published

    Wellness in work: The economic arguments for investing in the health and wellbeing of the workforce in Wales

    Edwards, R. T., Spencer, L., Anthony, B. & Bryning, L., 17 Oct 2019, Bangor: Bangor University. 64 p.

    Research output: Book/Report › Commissioned report › peer-review

26. Commissioned report › Research › Not peer-reviewed
27. Published

    A Synthesis of Qualitative Research Around Directly Observed Therapy and Tuberculosis.

    Noyes, J., Popay, J. & Garner, P., 1 Jan 2004, 2004 ed. Unknown.

    Research output: Book/Report › Commissioned report

28. Published

    A pilot clinical trial looking at the effect on lung cancer diagnosis of giving a chest X-Ray to smokers aged over 60 with chest symptoms: National Awareness and Early Diagnosis Initiative (NAEDI) Research Call Funding Partners Report

    Neal, R., Edwards, R., Yeo, S. T., Hurt, C. & The ELCID Team, Aug 2015

    Research output: Book/Report › Commissioned report

29. Published

    A review of economic models for second-line chemotherapy in the management of advanced, metastatic breast cancer.

    Hughes, D. & Hughes, D. A., 1 Jan 2001, 2001 ed. Unknown.

    Research output: Book/Report › Commissioned report

30. Published

    A study of the effects of the Carers Strategy in Wales on the needs of carers and the services they receive

    Seddon, D., Robinson, C. A., Russell, I. T., Woods, R. T., Tommis, Y., Reeves, C., Perry, J. K. & Boyle, M., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

31. Published

    AWMSG criteria for appraising new medicines.

    Hughes, D. & Hughes, D. A., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

32. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Abacavir 600mg/lamivudine 300mg (Kivexa) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

33. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Alemtuzumab (MabCampath) for the treatment of patients with B-cell chronic lymphocytic leukaemia for whom fludarabine combination chemotherapy is not appropriate.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

34. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Ambrisentan (Volibris) for pulmonary arterial hypertension.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

35. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Anidulafungin (Ecalta) for the treatment of invasive candidiasis in adult non-neutropenic patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

36. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-experienced patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

37. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Atazanavir (Reyataz) in treatment-naïve patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

38. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Buprenorphine/naloxone (Suboxone) as substitution treatment for opioid dependence.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

39. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Deferasirox (Exjade) for the treatment of chronic iron overload due to blood transfusions.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

40. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Docetaxel (Taxotere) for locally advanced squamous cell carcinoma of the head and neck.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

41. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Emtricitabine/tenofovir DF (Truvada)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2007, 2007 ed. Unknown.

    Research output: Book/Report › Commissioned report

42. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Epoetin delta (Dynepo)

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

43. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for STEMI.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

44. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Fondaparinux Sodium (Arixtra®) for UA/NSTEMI.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

45. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Icatibant (Firazyr) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

46. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Lenalidomide (Revlimid) for multiple myeloma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

47. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Maraviroc (Celsentri) for treatment-experienced adults infected only with CCR5-tropic HIV-1.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

48. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Pegfilgrastim (Neulasta) for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

49. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Raltegravir (Isentress) in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (HIV-1) infection in treatment-experienced adult patients with evidence of HIV-1 replication despite ongoing antiretroviral therapy.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

50. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Rufinamide (Inovelon) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS).

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

51. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Stiripentol (Diacomit) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

52. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Tacrolimus (Advagraf) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2009, 2009 ed. Unknown.

    Research output: Book/Report › Commissioned report

53. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Tenofovir disoproxil fumarate (Viread) for the treatment of hepatitis B.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

54. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Teriparatide (Forsteo) for the treatment of osteoporosis in men at increased risk of fracture.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

55. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Topotecan (Hycamtin®) for Small Cell Lung Carcinoma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

56. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Trabectedin (Yondelis) for advanced soft tissue sarcoma.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report

57. Published

    All Wales Medicines Strategy Group Final Appraisal Report - Ziconotide (Prialt) for the intrathecal treatment of severe, chronic pain.

    Hughes, D., Hughes, D. A. & All Wales Strategy Group., N. V., 1 Jan 2008, 2008 ed. Unknown.

    Research output: Book/Report › Commissioned report